Right now, doctors can’t tell whether women with DCIS will go on to develop breast cancer. This means that, unfortunately, some women with DCIS undergo unnecessary treatment. Find out how Jelle and his team are looking to change this.
Blueberry extract has been shown to improve success rate of radiation therapy in patients with cervical cancer.
‘Et tu, inhibitor?’: the potential for HIV inhibitors to prime P-gp-mediated chemoresistance in cancer
Discover the potential for HIV inhibitors to prime P-gp-mediated chemoresistance in cancer in this editorial from Future Science OA.
Find out about the characteristics of patient-derived xenograft models and their application for basic & preclinical cancer research in this editorial from Future Science OA.
In this interview Roshaine Wijayatunga (Senior Editor: Oncology) speaks with Michael Douek at the 2017 NCRI Cancer Conference 5–8 Nov 2017 about novel techniques for breast surgery and reconstruction.
A team of scientists have bound gene editing CRISPR/Cas9 to nucleotide aptamers to selectively target and edit osteosarcoma cancer cells.
Researchers at the Ludwig Institute for Cancer Research (Brussels, Belgium) have discovered a novel mechanism used by tumors to evade immunotherapies.
A team of researchers have reported T cells survive a tumor’s anoxic environment and become more effective at killing cancer cells by exploiting HIF-1a and when they have access to growth factor VEGF-A.
Find out about IMPACT, a partnership between Anthony Nolan, Leuka, NHS Blood and Transplant and the University of Birmingham (UK), which aims to deliver the UK’s first large-scale clinical trials program in this exclusive blog piece.
Researchers have demonstrated for the first time, in mice, that carbon nanotubes may pose a similar carcinogenic effect as asbestos.